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Technological developments in large-scale biological experiments, coupled with bioinformatics tools, have opened the doors to
computational approaches for the global analysis of whole genomes. This has provided the opportunity to look at genes within
their context in the cell. The integration of vast amounts of data generated by these technologies provides a strategy for identifying
potential drug targets within microbial pathogens, the causative agents of infectious diseases. As proteins are druggable targets,
functional interaction networks between proteins are used to identify proteins essential to the survival, growth, and virulence of
these microbial pathogens. Here we have integrated functional genomics data to generate functional interaction networks between
Mycobacteriumtuberculosisproteinsandcarriedoutcomputationalanalysestodissectthefunctionalinteractionnetworkproduced
for identifying drug targets using network topological properties. This study has provided the opportunity to expand the range of
potential drug targets and to move towards optimal target-based strategies.
1.Introduction
Throughout history, infectious diseases caused by micro-
bial pathogens have had a devastating impact on hu-
man morbidity and mortality, and they remain of great
concern, even today. With the advance of new high
throughput sequencing technologies, there has been an in-
crease in the number of worldwide microbial genome se-
quencing projects (http://microbialgenome.org, http://www
.ncbi.nlm.nih.gov/genomes/lproks.cgi?view=1, http://www
.sanger.ac.uk/Projects/Microbes and http://www.tigr.org/tdb/
mdbcomplete.html), which has yielded complete genome
sequences of crucial microbial pathogens of humans, ani-
mals, and plants. Analyses of these genome sequences
have provided valuable insights into the dynamics driving
pathogenic mechanisms and numerous virulence factors and
have shed light on the targeted organism’s biology [1]. The
characteristic features of pathogenic organisms include their
ability to colonize a speciﬁc host organ or tissue, to adapt to
their environment, and to evade the host immune response
[2], thus leading to the development of disease, as a result of
a delicate and dynamic balance between pathogen and host
defence system.
Furthermore, the availability of these pathogenic micro-
bial genomes can contribute to speeding up the process
of drug target selection [3] by ﬁnding genes that are
essential to microbial cell survival or growth and virulence.
In fact, signiﬁcant progress has been made in drug dis-
covery and vaccine administration against major infectious
diseases [4]. However, these eﬀorts are weakened by an
increased incidence of widespread drug-resistant strains to
the available and commonly used antibiotics and vaccines,
a growing prevalence of infections, and the emergence
of new pathogenic organisms, making infectious diseases
the leading cause of human death worldwide. Tuberculosis
(TB) is the biggest component of these infectious diseases,
which claimed 1.8 million victims in 2008, and there were
estimates of 9.4 million new cases that year (3.6 million2 Advances in Bioinformatics
of whom are women), including 1.4 million cases among
people living with Human Immunodeﬁciency Virus (HIV)
or Acquired Immunodeﬁciency Syndrome (AIDS) according
to the World Health Organization (WHO) [5, 6].
TB is caused by an intracellular pathogen Mycobacterium
tuberculosis(MTB),alsoknownastubercleorKoch’sbacillus,
whose genome sequence has been completely elucidated [7–
9]. The complete elucidation and publication in 1999 [8]
of the ﬁrst MTB genome sequence constitutes the biggest
step towards understanding MTB virulence and its speciﬁc
abilities for invasion and division inside host macrophages.
Thishasfacilitatedtheidentiﬁcationandfunctionprediction
of all MTB proteins and the identiﬁcation of genes common
to all bacteria or speciﬁc to MTB. Even though there are
still a large number of uncharacterized genes, which limits
genomic studies, such data has provided a basis for selecting
potential drug targets from the complete list of proteins.
The genes in the MTB genome, but missing from closely
related genomes, are likely to be crucial to its pathogenicity
and constitute promising candidates for drug targets [3].
This shows that the use of available data and computational
methods may help us better understand the mechanisms of
virulence of MTB and features that enable this organism to
adapt to or evade the host immune response.
Several biological studies have shown that a protein is a
“social animal” [10–13], that is, a protein does not achieve
its function alone but cooperates with other proteins to
perform that function. Thus, most processes in a living cell
are accomplished through protein-protein interaction net-
works; therefore, these play a central role in most activities
involvingthestructureandfunctionofthecell.Theseinclude
signal transduction, protein folding, cell cycle control,
DNA replication and transport, cellular motion, and most
regulatory mechanisms [14, 15]. These interactions are of
various types, but a high level description of biological
systems partitions them into two categories, namely, phys-
ical and functional interactions [16]. Physical interactions
refer to physical contact between proteins, and functional
interactions or relationships between proteins involve the
mechanism through which a particular protein achieves its
functions. While “functional interactions” between proteins
suggest direct physical contact between them [17], it is
actually a broader concept and does not necessarily involve
direct physical interactions [15].
In this work, we only refer to functional interactions,
including physical and genetic interactions, and those de-
rived from knowledge about coexpression and shared evo-
lutionary history or pathways. Proteins interact directly or
indirectly through one or more intermediates to carry out
their functions in promoting the stability and robustness
of the system. These interactions can be modeled as a
network, called a protein-protein functional network or
interactome. This is a network in which nodes or ver-
tices are proteins and edges or links represent pairwise
interactions or functional relationships between proteins
within an organism. Analytically, protein-protein functional
interaction networks are represented as a couple G(N,L),
where N is the set of proteins (nodes) and L the set of
functional relationships (links), and graphically visualized
using an undirected graph layout representing the paths
of communication and metabolism of an organism. Even
though interaction networks do not directly encode cellular
processes nor provide information on dynamics, they do
representaﬁrststeptowardsdescriptionofcellularprocesses,
which are ultimately dynamic in nature [18], and they
constitute a signiﬁcant step toward understanding the func-
tional organization of the cell [15]. Therefore, knowledge of
protein-protein networks might advance our understanding
of biological systems including molecular pathways and
elucidate the role of various proteins in complex diseases and
how they cooperate to achieve a higher goal in the host.
The most commonly used integrated functional inter-
action networks for many organisms [19–21] are obtained
from the Search Tool for the Retrieval of Interacting
Genes/Proteins (STRING) database [22, 23]. The STRING
scoring system for protein or gene interactions is bench-
marked by the Kyoto Encyclopedia for Genes and Genomes
(KEGG) database [24] in which only 1028 out of more
than 4000 encoded proteins in the MTB proteome have
a known pathway, representing about 25%. This consti-
tutes the biggest limitation for scoring newly discovered
interactions between genes and/or proteins, speciﬁcally for
MTB, which is not a model organism. In addition, the
experimental data in the STRING database for this par-
ticular organism is limited. As an illustration, when deal-
ing with microarray data, the STRING database retrieves
its coexpression interactions from ArrayProspector (http://
www.bork.embl.de/ArrayProspector)[ 25]. However, a large
amount of microarray data for MTB are being generated
and are publicly available in other resources, and these may
increase the accuracy and precision of STRING data. In
the case of homology data, the STRING scoring system
uses the E-value obtained from sequence similarity searches.
However, there are also protein signature databases such as
InterPro [26], which is an integrated database for protein
families and domains (http://www.ebi.ac.uk/interpro)[ 27]
and can be used to increase the reliability and coverage
of these homology data. Therefore, there is a need for an
eﬀective scoring system to ﬁll gaps found in homology
and microarray data in STRING for this speciﬁc organism
to produce a more complete MTB functional interaction
network.
To obtain a high coverage protein-protein interaction
network, every functional relationship or interaction be-
tween proteins should be depicted. These interactions are
discovered by various experimental approaches and often
partially complemented with prediction techniques [22].
One of the subjects of heated debate around protein-
protein interaction networks is that a network obtained
from high-throughput experiments roughly maps the “cur-
rent” network of interactions occurring inside the cell. In
addition, there are several issues related to high-throughput
data, including noise, environment, and the nature of the
approaches used for each experiment [28]. Thus, each
speciﬁc approach may incorrectly classify interactions, that
is, either failing to detect interactions, referred to as false
negatives or wrongly identifying some other interactions,
referred to as false positives. The lack of appropriateAdvances in Bioinformatics 3
techniques to address these shortcomings results in biases
in the outputs and this is obviously a technology-dependent
problem. In order to alleviate the former issue, data integra-
tion combining information from multiple interacting data
sources into one uniﬁed network is deployed, leading to a
higher conﬁdence and an increased coverage. For the latter
issue, a reliability threshold is applied, thus discarding all
functional interactions whose reliability or conﬁdence score
is less than the threshold. These techniques are expected to
signiﬁcantly reduce the false negative and positive rate of
the network produced, thus yielding a network of high con-
ﬁdence interactions.
For the Mycobacterium tuberculosis (MTB) strain
CDC1551, we used contributions from both primary data,
such as genomic sequences and functional data from high-
throughput experiments, to construct a protein-protein
functional interaction network. Such a network allows us
to unravel the underlying principles of its biological
properties for the purpose of building a predictive disease
model and identifying novel therapeutic drug targets. We
performed computational analysis on the network to detect
the key principles driving the biological organization of
the organism and to identify proteins that are potentially
indispensable for the survival and viability of the organism,
referred to as essential proteins, and those which contribute
to the ﬁtness of the organism, referred to as supplementary
proteins. We explored (1) the interplay between each protein
pair in the network and their possible contribution to
disease and (2) how they reliably function for the survival
and ﬁtness of the organism on the basis of the network
topology. This categorization can provide clues toward
ﬁnding eﬀective drug targets and possibly lead to new
antituberculosis compounds with novel mechanisms of
action against essential proteins [29].
2.MaterialsandMethods
An MTB functional interaction network was built by inte-
grating interaction datasets from the STRING database and
additional interaction data derived from sequence similarity
and signature, and microarray data. The STRING database
[22, 23] integrates known and predicted protein-protein
associations derived from high-throughput experimental
data,theminingofdatabasesandliterature,andfrompredic-
tions based on genomic analysis for a large number of organ-
isms. Functional interactions from the STRING database
are used with conﬁdence scores as deﬁned by the STRING
schemes. These include conserved genomic neighbourhood,
gene fusion events, phylogenetic proﬁle, or gene cooccur-
rence across multiple genomes, text mining, experiments,
and other databases (http://string-db.org/). Additional inter-
action data are derived from protein sequence similarity and
signatures, and microarray data. Functional interaction pairs
predicted from protein sequence similarity and conserved
protein signatures are scored using information theoretic-
based approaches which translate into conﬁdence scores for
protein conserved features from evolution [30]. We used
a random partial least squares regression technique for
inferring genes with similar expression proﬁles from mul-
tiple public microarray datasets and generating functional
connection scores between proteins [31]. The combined
link conﬁdence score between two proteins i and j for an
integrated view of all datasets through a uniﬁed network as
shown in Figure 1 is given by
Sij = 1 −
9  
d=1
 
1 − sd
ij
 
(1)
under the assumption of independency, and where sd
ij is the
conﬁdence score of a functional interaction between i and j
predicted using the type of data d.
This section describes network centrality measures that
are used to numerically characterize the importance of pro-
teins in the system, and their contribution to the functioning
of the system, thus assessing the topological signiﬁcance
of these proteins within the network and quantifying the
structural properties of the functional network produced.
These measures include degree or connectivity, betweenness,
closeness, and eigenvector centrality metrics. We denote
by G(N,L) the MTB functional network, with N the
set of interacting proteins and L the set of functional
interactions or connections between proteins, represented by
the adjacency matrix A,a nn × n symmetric matrix, where
n =| N | is the number of proteins in the network and whose
components apq are deﬁned as follows:
apq =
⎧
⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎩
1 if the protein p is functionally linked to
the protein q,
0, otherwise.
(2)
Proteins in N are numbered from 1 to n, and a protein p
is represented by its position number denoted by p.T h e
adjacency matrix A is symmetric, since if the protein p is
functionally linked to the protein q, then clearly the protein
q isalsofunctionallylinkedtotheprotein p.Notethatagiven
protein pisnotfunctionallylinkedorconnectedtoitself,that
is, app = 0.
π(p,q) denotes the distance between proteins p and q or
the length of the shortest path from a protein p to a protein
q, that is, the number of links in the shortest path between
p and q for an unweighted graph; the shortest path between
proteins being the path with the minimum number of edges
connecting these proteins. If no path exists between proteins
p and q, then π(p,q) =∞ .
2.1. Degree and Betweenness Centrality Metrics. The degree
or connectivity of a protein p is the number of links con-
nected to it, that is, the number of its interacting neighbors
[32]g i v e nb y
deg
 
p
 
=
 
q∈N
δ
 
p,q
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Figure 1: Data integration scheme.
where
δ
 
p,q
 
=
⎧
⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎩
1 if the protein q is functionally linked to
the protein p,
0 otherwise.
(4)
In terms of the adjacency matrix A, the degree of a protein
p is simply the sum of components in the row or the column
corresponding to the protein p,g i v e nb y
n  
q=1
apq = deg
 
p
 
=
n  
q=1
aqp. (5)
In fact, the degree or connectivity of a protein provides an
indicator of its inﬂuence on the biological processes occur-
ringintheorganism,meaningthataproteinwithmorefunc-
tional connections tends to contribute to several processes,
and may thus be a key protein in the functioning of the
system.
The betweenness centrality of a protein p in a functional
network is a metric that expresses the inﬂuence of p relative
to other proteins within the network. It is based on the
proportion of shortest paths between other proteins passing
through the protein target [33] and shows the importance of
a protein for the transmission of information between other
proteins in the network. This metric provides an indication
of the number of pairwise proteins connected indirectly by
the protein target through their direct functional connec-
tions. The betweenness, B(p), of a protein p is given by
B
 
p
 
=
 
(s,t)∈Np
σst
 
p
 
σst
, (6)
whereσst(p)isthenumberofshortestpathsfromproteinsto
protein t passing through p, σst the number of shortest paths
from s to t in the functional network, and Np ={ (s,t) ∈
N × N : s / = p / =t and s / =t}. The normalized betweenness
of a protein p, lying between 0 and 1, is given by
B
 
p
 
=
1
(n −1)(n −2)
 
(s,t)∈Np
σst
 
p
 
σst
. (7)
Thus, proteins with high betweenness are expected to ensure
the connectivity between proteins in the functional network
and are able to bridge or disconnect connected components.
As the MTB functional network generated has a scale-free
property, such proteins are hubs, referring to proteins that
are highly connected and serve to hold together a large
number of proteins with low degree, thus integrating all
proteins in a given connected component into a uniﬁed
complex system. These proteins are of utmost importance
for the integrity and the robustness of the system and are
responsible for the small world property since connections
between proteins are relatively short via these hubs.
2.2. Closeness and Conﬁdence Measures of a Protein. The
status, S(p), of a protein p in a connected network is theAdvances in Bioinformatics 5
average distance to all other proteins, that is, the ratio of the
sum of π(p,q) for all proteins q in the network to the total
possible number of such paths, which is (n−1). It is given by
S
 
p
 
=
1
(n −1)
 
q∈N
π
 
p,q
 
. (8)
The closeness measure, Cs(p), of a protein p is the inverse
[32] of its status and reﬂects the ability of the protein
to access information via other proteins and to propagate
information through the network. As the MTB functional
network is not completely connected, this closeness measure
is calculated for each connected part separately and normal-
ized to (nc − 1)/(|Lc|−1) [34], where nc is the number of
nodesintheconnectedpartofthegraphcontainingthenode
and |Lc|itssize,thatis,thenumberoffunctionallinksinthe
connected component. This is to make the scale uniform for
comparison. Thus, the closeness measure of a protein p is
given by
Cs
 
p
 
=
|Lc|−1
(nc − 1) × Sr
 
p
 ,( 9 )
where Sr(p) is the status of p relative to its connected com-
ponent.
The closeness measure is high for a protein that is central
since it has a shorter distance on average to other proteins.
We deﬁne the center of gravity Gc of the network as the set
of proteins that maximize the closeness measure to any other
protein in the network, given by
Gc =
 
p ∈ N : Cs
 
p
 
= max
q∈N
Cs
 
q
 
 
. (10)
Theeccentricity,E(p),ofaprotein p inagivenconnected
graph is the maximum length of shortest paths from protein
p to all other proteins in the network, that is,
E
 
p
 
= max
 
π
 
p,q
 
: q ∈ N
 
. (11)
In the context of the MTB functional network, the eccentric-
ityE(p)ofaproteinpiscomputedaccordingtoitsconnected
component, and we consider the inverse of the eccentricity
obtained, and normalize it, as done previously. The measure
is referred to as the conﬁdence Ce(p)o fp r o t e i np, expressing
its capability to quickly communicate with other proteins in
the network, and given by
Ce
 
p
 
=
|Lc|−1
(nc −1) ×Er
 
p
 , (12)
where Er(p) is the eccentricity of p relative to its connected
component.
The higher the conﬁdence of a protein in the functional
network, the quicker it communicates with other proteins in
the network. We deﬁne the reference center Rc of the net-
work as the set of proteins that maximize the conﬁdence of
any other protein in the network, given by
Rc =
 
p ∈ N : Ce
 
p
 
= max
q∈N
Ce
 
q
 
 
. (13)
2.3.EigenvectorCentralityMetric. Thedegreeorconnectivity
metric provides a simple number of functional connections
without weighting them. The eigenvector metric considers
the importance or weight of these functional connections
[32]. In fact, functional connections are not equally impor-
tant and functional connections to more inﬂuential proteins
will impact more on the contribution of the protein than
functional connections to less inﬂuential proteins. Thus, the
eigenvector centrality metric assigns a relative weight to all
proteins in the network based on the fact that functional
connections to proteins of high weight contribute more to
the weight of the protein target.
Let cp be the numerical value representing the contribu-
tion of the protein p to the functioning of the system. cp is
then proportional to the contributions of its neighbors to the
system. This means that
n  
q=1
apqcq = λcp, (14)
where λ is constant for every protein p in the functional
network. In matrix form, this can be written as follows:
Ac = λc, (15)
where c = (c1,...,cn)
T, the transpose of the vector (c1,...,
cn), which deﬁnes a vector of contributions of each protein.
The vector c is an eigenvector of the adjacency matrix A
associated with eigenvalue λ. It is known that λ is the largest
eigenvalue of the adjacency matrix and c is its nonnegative
corresponding eigenvector [32, 35]. In this metric, the
contribution of a given protein to the functioning of the
system depends not only on the number of its interacting
neighborsbutalsoonthequalityoftheseneighbors.Proteins
witha high number of functional interactions are important,
but a protein with a small number of high-quality functional
connections may contribute more to the survival of the
organism than one with a large number of low-quality
functional connections.
3. Results and Discussion
We have generated an MTB functional interaction network
from nine biological data sources, and the summary of
number of interactions and conﬁdence scores is shown in
Table 1. For each evidence source, functional interaction
scores are categorized into three diﬀerent conﬁdence levels,
namely, low, medium, and high conﬁdence. The ﬁnal row
shows the number of interactions in each conﬁdence range
for the ﬁnal combined score. Note that for a given data
source, all interactions whose scores are strictly less than 0.3
(<0.3) are considered as low conﬁdence, scores ranging from
0 . 3t o0 . 7( 0 .3 ≤ score ≤ 0.7) are classiﬁed as medium
conﬁdence, and scores greater than 0.7 (>0.7) yield high
conﬁdence. Furthermore, the conﬁdence increases when
interactiondataareintegratedintoasinglenetwork,produc-
ing more medium and high conﬁdence links in the last row
than when considering only one type of data. To understand
the biological organization of the organism from its protein6 Advances in Bioinformatics
functional network and use this as a means to develop
appropriate treatment strategies for the disease, complete
knowledge of the network structure and the contribution of
each protein to the system’s biological processes are required.
To this end, network centrality measures are used to reveal
proteins which are potentially crucial to the functioning
of the system, thus contributing to the survival of the
organism.
3.1. General View of the MTB Functional Network. The use
of these nine diﬀerent biological sources is expected to
solve the problem of interaction incompleteness. On the
other hand, to reduce the impact of bias in functional
interactions coming from experimental predictions and
computational approaches, we have only considered those
ranging from medium to high conﬁdence and for functional
interactions with low conﬁdence, only those predicted by
at least two diﬀerent approaches were considered. In total,
5 interactions of low conﬁdence predicted by at least two
diﬀerent approaches have been included in the functional
network. We analyzed the network for its general properties,
and these network parameters are presented in Table 2.
The network is comprised of 4136 proteins out of 4195
found in the complete list from the UniProt database [38–
40],coveringapproximately98.6%oftheMTBproteome.Of
these, 201 are structural hubs, or “single points of failure”,
which are able to disconnect the network, thus aﬀecting
function, and they are considered to be responsible for the
integrity of the system. Due to the presence of these hubs,
any pairwise protein set in a given connected component can
communicate through its relative shortest paths. In the MTB
functional network, the average path length, obtained by
averaging over all shortest paths between all pairs of nodes,
is approximately 4 as shown in Figure 2 representing the
probability distribution of the shortest path length.
This reveals that the transmission of biological infor-
mation from a given protein to others is achieved through
only a few steps. Indeed, the average shortest path length
value is 3.678, which is approximately of the order of
magnitude log(|N |)w i t h|N |=4136. This means that
the MTB functional network has a “small world property”
[41, 42], and the value provides an idea about the network
navigability, indicating how fast the information can be
spread in the system independently of the number of
proteins. This property may also provide the organism with
an evolutionary advantage in the sense that the system
w o u l db ea b l et oe ﬃciently respond to perturbations in the
environment and to quickly exhibit a qualitative change of
behaviour in response to these perturbations.
We further performed analysis of the degree distribution
of the MTB functional network and, as shown in Figure 3,
the functional network exhibits scale-free topology, that is,
the degree distribution of proteins approximates a power law
P(k) = k−γ, with the degree exponent γ ∼ 1.45. This means
that most of the proteins have few interacting partners but
some have many partners. The latter are referred to as “high
degree nodes” and probably ensure some basic chemical
operations such as energy transfer and redox reactions,
essential for the survival of the organism.
02468 1 0 1 2
Path length: ℓ
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
F
r
e
q
u
e
n
c
y
:
P
(
ℓ
)
Figure 2: Distribution of shortest path lengths between reachable
pair-wise protein functional interactions.
0 50 100 150 200
Detected protein degree: k
0
0.01
0.02
0.03
0.04
0.05
0.06
Connectivity distribution: P(k)
C
o
n
n
e
c
t
i
o
n
s
f
r
e
q
u
e
n
c
y
:
P
(
k
)
Power-law: P(k) ≃ k−1.45
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per protein, plotted as a function of frequency P(k).
3.2. Assessing High-Degree Proteins. The MTB functional
networkexhibitsa“scale-free”property,assuchitisexpected
to be vulnerable against targeted attack and robust against
random attack. The robustness of the system is observed
through its stability, expressed by its ability to remain
nonvulnerable under changing environmental conditions or
stressful perturbations due to a protein knockout or attack.
Topologically,thiscanbeseenasthepotentialconnectivityof
the network under a protein disruption. Thus, to assess the
topological essentiality of MTB proteins, we classify them in
two categories, namely, proteins with a high degree referred
to as degree-based hubs and those able to disconnect the
functional network, known as structural hubs. A protein is
considered to be a degree-based hub if its degree is above the
average degree of proteins in the MTB functional network,Advances in Bioinformatics 7
Table 1: The number of associations in the MTB functional network, shown separately for each data source and conﬁdence range from low
to high.
Association evidence by type Low conﬁdence Medium conﬁdence High conﬁdence
Conserved genomic neighbourhood 1163 6972 4731
Gene fusion events 337 52 99
Phylogenetic Proﬁle 1033 5862 1461
Text mining 1174 722 93
Experimental 220 170 133
Knowledge from database 3 970 2002
Sequence similarity 8524 1345 77
Shared domains 0 20915 17792
Coexpression 6538 225 4
Combined score 6850 32488 25605
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Figure 4: Assessing network vulnerability under random and targeted attacks.
Table 2: General MTB functional network parameters.
Parameters Value
Number of proteins (Nodes) 4136
Number of functional interactions (Edges) 58098
Average degree (in and out) 28
Average shortest path length 3.678
Number of connected components 23
%o fN o d e si nl a r g e s tc o m p o n e n t 9 8 . 7 %
Number of hubs 201
which is 28. We ﬁrst observe the changes in the number of
connected components and in the number of proteins in the
largest connected component by repeatedly (1) knocking out
randomly selected proteins referred to as random attacks,
(2) disrupting the highest degree proteins, referred to as
degree-based hub attack, and (3) removing proteins able to
disconnect the network, referred to as structural hub attack.
To simulate an attack, a given number of proteins are chosen
for each category and the process is repeated 1000 times
by randomly choosing proteins and computing the average
number of the resulting components and the number of
proteins in the largest component. Results are shown in
Figure 4 and indicate that the MTB functional network is
vulnerable to targeted structural hub attacks.
Indeed, the more structural hubs removed, the higher
the number of connected components. This means that the
more structural hubs are removed, the more the network is
disintegrated, whereas the disruption of randomly selected
proteins, or of degree-based hubs, does not perturb the
general structure of the network. This means that structural
hub proteins play an essential role in the network integrity.
Therefore, knocking out these proteins may disturb the
functioning of the system and negatively impact on the8 Advances in Bioinformatics
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Figure 5: Analyzing the variations in the betweenness metric in
terms of protein category.
ability of this pathogenic bacterium to carry out its role in
the host. We have also analyzed the network connectivity
by observing the size of the largest connected component.
Figure 4(b) shows that the size of the largest component
rapidly decreases when structural hubs are disrupted. This
indicates that the network is disintegrated into several small
connected components, thus showing the role played by the
structural hubs in maintaining the network connectivity.
3.3. Assessing Central Proteins. The betweenness metric rep-
resents a signiﬁcant indicator of network essentiality [42].
Proteins with high betweenness are essential to the func-
tioning of the system, serving as bridges for communication
between several other proteins in the network. A protein
with high conﬁdence or closeness will be more important
becauseithasasmallerpathlengthtoreachallotherproteins
in the network, allowing the system to quickly exhibit
appropriate behaviour in case of a given perturbation in
the system. Figures 5 and 6 show the functional importance
of proteins obtained by ordering proteins by betweenness,
closeness, and conﬁdence measures of hubs and observing
the cumulative proportion for every 10 proteins. These
results reveal that proteins with high degrees and located
in the center of the network may reach all the nodes in
a given connected component with fewer steps compared
to the structural hubs. These results combined with those
in Figure 6 suggest that a protein, which is a structural
hub and has a high degree, is important for the survival
of the bacterial pathogen. These proteins are considered to
be potential drug targets and can be used to enhance the
discovery process of new antibiotics with novel mechanisms
of action to treat the disease.
3.4. Important Proteins in the MTB Functional Network. We
investigated the biological signiﬁcance of proteins found
to be structurally important in the functional network.
Speciﬁcally, we are looking at the functions that are carried
out by proteins found in the center of gravity Gc with high
betweenness and connected to some inﬂuential proteins at
certain levels, that is, proteins with eigenvector centrality
greaterthan10−5.Wearealsointerestedinthebiologicalpro-
cesses in which they are involved, as well as in the functional
class to which they belong. This enables the identiﬁcation
of proteins that are potentially essential for the survival of
the bacterial pathogen, as they correspond to bottlenecks
in the MTB functional network and are, therefore expected
to be key components of the organism’s cellular processes.
Bottleneck proteins are proteins responsible for several
indirect functional connections between other proteins in
the functional network. As the average shortest path length
is 3.678, a protein in the functional network is said to belong
to the gravity center if its closeness metric, as deﬁned in
(9), is greater than 1/3.678, which represents approximately
0.27189. In the case of the betweenness measure, a protein
with betweenness above the total number of shortest paths
expected to pass through the protein in the functional
network is of interest, and this number is about 15212.21.
Through these, we identiﬁed a set of 881 proteins, which
constituteasetofimportantproteinsandthuspotentialdrug
targets within the bacterial pathogen.
It is diﬃcult to validate a set of potential drug targets
computationally, and of course there are many other factors
involved in determining suitability as a drug target, apart
from the target having a potentially important functional
role. However, we tried to assess the candidate list by looking
at some known drug targets as well as targets predicted
by other groups. We identiﬁed “validated” drug targets in
MTB on the TDR targets website (http://tdrtargets.org).
According to their documentation, these validated targets
are manually curated from the literature. We also checked
UniProt annotation for MTB, searching for the “Miscel-
laneous” comment “was identiﬁed as a high conﬁdence
drug target”, and looked at a handful of genes reported
to be predicted drug targets in a table of a recent paper
by Kinnings et al. [36]. Table 3 in this paper [36] lists 12
genes with a high “Target Chemical Druggability Index”. Our
list of candidate drug targets includes 33 genes which were
TDR validated targets, 7 of which were also in the UniProt
target list, and 1 of which was also predicted by Kinnings
et al. Our list included an additional 6 proteins from the
Kinnings prediction, and an additional 75 proteins in the
UniProt target list. Therefore, 114 proteins in our candidate
list have previously been predicted or reported to be drug
targets. Within this set are four known targets of existing
antitubercular drugs. Two genes, inhA and folA, are known
to be targets of or aﬀected by isoniazid (inhA was also on the
TDR, UniProt, and Kinnings list), embA is a known target of
ethambutol, and rpoB is involved in rifampicin resistance.
One protein known to be involved in activating isoniazid,
KatG, was not on the list, but when we checked its network
properties, its closeness and betweenness measures were only
just below the cut-oﬀ for inclusion.
Further functional analysis on the candidate list was
performed using a small group of high level functionalAdvances in Bioinformatics 9
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Figure 6: Assessing the variations in closeness and conﬁdence centrality measures in terms of protein category.
Table 3: Summary of overrepresentation analysis of functional classes for diﬀerent protein sets based on network properties.
Protein set Overrepresented function P value Adjusted P value
Hubs PE/PPE 2.10576e −05 1.89518e −04
Degree ≥ 100 Lipid metabolism 4.37537e −12 1.96891e −11
Intermediary metabolism and respiration 1.06668e −25 9.60013e −25
Lipid metabolism 2.33426e −08 7.00278e −08
Degree 50–99 Information pathways 0.0209259 0.0470832
Regulatory proteins 1.91556e −52 8.62003e −52
PE/PPE 8.196e −115 7.3764e −114
Lipid metabolism 0.00358115 0.0080576
Intermediary metabolism and respiration 1.33874e −58 1.20487e −57
Degree 10–49 Information pathways 2.6561e −10 7.96829e −10
Virulence, detoxiﬁcation, adaptation 4.90211e −11 2.20595e −10
Unknown 4.98171e −180 4.48354e −179
Degree <10 Cell wall and cell processes 4.47945e −04 1.78646e −03
Insertion seqs and phages 5.95487e −04 1.78646e −03
Lipid metabolism 2.03723e −04 3.66702e −04
Intermediary metabolism and respiration 5.99428e −08 1.79828e −07
Betweenness >15 000 Information pathways 1.54837e −06 3.48383e −06
Regulatory proteins 3.51658e −08 1.58246e −07
PE/PPE 4.48875e −11 4.03987e −10
Closeness >0.5 Unknown 2.58864e −14 2.32978e −13
Eigenvector >0.08 Lipid metabolism 1.5511e −12 6.97994e −12
Intermediary metabolism and respiration 2.85447e −31 2.56902e −30
Lipid metabolism 2.68651e −05 4.83571e −5
Intermediary metabolism and respiration 2.12524e −11 9.56358e −11
Drug target Information pathways 4.13904e −07 9.31285e −07
Regulatory proteins 6.36758e −08 1.91027e −07
PE/PPE 1.53973e −12 1.38576e −1110 Advances in Bioinformatics
Table 4: Repartition per class of potential drug target proteins, considering those which are central and those considered to be more inﬂu-
ential.
Functional class Proteins Drug targets Central targets Inﬂuential targets
1 Virulence, detoxiﬁcation, adaptation 176 31 2 1
2 Lipid metabolism 230 75 35 28
3 Information pathways 245 85 21 —
4 Cell wall and cell processes 618 112 52 5
5 Insertion seqs and phages 82 10 — —
6 PE/PPE 147 69 2 —
7 Intermediary metabolism and respiration 884 262 93 70
8 Unknown 1637 169 24 10
9 Regulatory proteins 176 68 12 —
Total 4195 881 241 114
Table 5: Summary of network properties of protein sets from the total proteome in the network, those required for normal growth and
those required for survival during infection.
Metric Total Growth Survival
Average eigenvector 0.003403 0.004342 0.003486
Average betweenness 10792.87 16108.18 11487.32
Average closeness 0.28629 0.298827 0.287806
Average degree 28.082 36.95911 33.17778
% Hubs 4.859768 0.851789 3.888889
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Figure 7: Distribution of candidate drug targets per functional
class.
classes assigned to all the proteins. These functional classes
were extracted from TubercuList (http://genolist.pasteur.fr
TubercuList/), and the distribution of these potential drug
targets per functional class is shown in Figure 7. These
results indicate that most of the candidate drug targets
are involved in intermediary metabolism, followed by a
signiﬁcant proportion of proteins in the unknown class and
those belonging to the cell wall and cell process functional
classes. We used the Fisher’s Exact Test to ﬁnd overrepre-
sented functions in sets of proteins with diﬀerent network
properties. Table 3 shows that the hub, high degree (50–
99), and high betweenness proteins, as well as the predicted
drug target list are signiﬁcantly over-represented by PE/PPE
proteins. Note that this distinct functional class consists of
proteins whose sequences have characteristic motifs Pro-Glu
at positions 8-9 and Pro-Pro-Glu at 8–10 [1], where Pro and
Glu stand for Proline (P) and Glutamic (E) amino acids.
Most of these proteins are speciﬁc to mycobacteria and have
been suspected to allow MTB to adapt to its environment
during infection or transmission [43] and to play a role in
its virulence or immunogenicity [44, 45] by altering the way
thehostrespondstotheinfection.Lipidmetabolismproteins
also feature highly in most of these lists, and regulatory
proteins in some of these. One would expect regulatory
proteins to be reasonably well connected as they are likely
to have an eﬀect on multiple genes. Interestingly, the high
closeness measure proteins tend to be from the unknown
class. The drug target list also contains 31 proteins belonging
to the virulence, detoxiﬁcation, and adaptation functional
class.
We also identiﬁed within the candidate drug target list,
proteins which are either more central (top ranked closeness
values) or more inﬂuential (top ranked eigen values) in the
system and classiﬁed them per functional class, and these
results are shown in Figure 7 and in Table 4. These results
again show that most of the potential drug targets that are
central to the functioning of the system, ensuring quick
communication between proteins in the system, are involvedAdvances in Bioinformatics 11
Figure 8: An illustration of a structural hub protein. Nodes are coloured by functional class: virulence (light-green), PE/PPE (yellow), cell
wall and cell processes (green), lipid metabolism (light-blue), intermediary metabolism and respiration (grey), and unknown (white).
in intermediary metabolism and respiration, cell wall and
cell processes, and lipid metabolism. Some of the known
antitubercular drugs target cell wall biosynthesis and lipid
metabolism, in particular synthesis of mycolic acids. Those
involved in intermediary metabolism and respiration, as well
as lipid metabolism, are connected to proteins participating
in several processes, thus playing key roles in the system.
Many of the more inﬂuential and/or more central pro-
teins include previously reported drug targets, for example,
inhA, which is both central and inﬂuential. Therefore, these
criteria could be used to rank the 114 targets. However,
there are also some highly inﬂuential and central proteins
in the complete candidate list that have not previously
been identiﬁed or characterized. One of the predicted drug
targets is the protein “MT1917” (UniProt accession P95147)
shown in Figure 8. This protein is a structural hub but is
uncharacterized and has been identiﬁed to be a central and
inﬂuential target. It is shown to be linked to a number of
proteins with various diﬀerent functions and is an example
of a protein that should be further investigated as a potential
drug target. There are many other novel candidates with
these properties, but which have also been shown to be
essential for growth [37] or intracellular survival [46] that
could be pursued.
Sassetti and colleagues [37, 46] published two lists of
genesfromMTBH37Rvthathavebeenshowntobeinvolved
in either normal growth or for survival during infection.
These genes were mapped to CDC1551 identiﬁers using
the orthologues ﬁle from the EBI Integr8 project [47]
(http://www.ebi.ac.uk/integr8) and the network properties
for these genes are summarised in Table 5. The set of
genes required for normal mycobacterial growth tend to
have higher average Eigenvector, betweenness, closeness, and
degree values than the overall proteome. For those required
for infection, these values are generally higher than the total
average, but not as high as for the growth set. Of the 881
drug target proteins, 197 are on the list of proteins required
for growth, and 38 are on the list of proteins required for
survival during infection. This enhances their suitability as
drug targets, since they have been shown experimentally to
be required by the organism. 51 of the proteins required
for growth and 7 proteins required during infection overlap
with the 114 previously predicted drug target list mentioned
above. Based on diﬀerent criteria, we have ranked our
complete list and show the top 10 candidates in Table 6.
4. Conclusions
In this study, we have produced an MTB functional network
andelucidatedproteinswhichareessentialtothefunctioning
of the system using the network centrality measures. We
showed that proteins contributing to the survival of the
bacterial pathogen within the host are potential drug targets
andmanyhavepreviouslybeenidentiﬁedassuchbydiﬀerent
methods. These data can be used to enhance the discovery
process of new drugs in order to overcome the disease caused
by this particular organism, which currently constitutes a
public health challenge.
Drug targets have been traditionally identiﬁed through
complete knowledge of individual proteins and their well-
characterized functions. Here, we integrate biological data
from diﬀerent sources into a single functional network to
provide a systems view of the whole bacterial pathogen for
the identiﬁcation of new potential drug targets. This has
enabled us to identify key proteins which are still uncharac-
terized. It might help us to better understand the biology of
the organism as a whole system and may constitute a useful
tool for orienting further experiments. Furthermore, this12 Advances in Bioinformatics
Table 6:Top10drugtargetcandidatesrankedbasedoncriteriasuchashigheigenvector(inﬂuential)andcloseness(central)values,previous
identiﬁcation as a possible target, and essentiality.
UniProt
Acc Gene name Functional class
Network centrality scores Previous identiﬁcation sources
Eigen Betweenness Closeness Degree TDR UniProt Drugome
[36]
Essential
[37]
Q7D6Z3 MT2600 Lipid metabolism 0.08369 128207.32 0.37 207 Yes Yes
P0A5Y6 inhA Lipid metabolism 0.08216 27379.65 0.36 162 Yes Yes Yes
O06934 glf Cell wall and cell
processes 0.08152 67825.15 0.36 172 Yes
Q11141 proC
Intermediary
metabolism and
respiration
0.08123 57376.99 0.36 165 Yes Yes
P63562 argC
Intermediary
metabolism and
respiration
0.08119 51684.48 0.36 163 Yes Yes
P63629 hom
Intermediary
metabolism and
respiration
0.08137 50079.08 0.36 171 Yes Yes
P64328 hemA
Intermediary
metabolism and
respiration
0.08126 77831.05 0.36 173 Yes Yes
P0A544 serA
Intermediary
metabolism and
respiration
0.08133 28205.61 0.36 164 Yes Yes
P66783 Rv3791
Intermediary
metabolism and
respiration
0.08162 27347.66 0.35 157 Yes Yes
O33290 ftsK Cell wall and cell
processes 0.00172 62658.74 0.35 97 Yes Yes
may contribute to the process of developing new antibiotics
with novel mechanisms of action for better treatment of the
disease by saving time and reducing the cost.
By combining our predicted candidate list with other
drug target lists as well as gene essentiality data, we can
rank the candidates according to diﬀerent criteria. Some
of the known targets for existing anti-tubercular drugs are
not in the Sassetti et al. essential gene lists, and some
of the previously reported targets are not necessarily the
most central or inﬂuential; therefore, there does not appear
to be a single rule for identifying the best targets. It is
through integration of data that we will become better
informed on target suitability. The Kinnings et al. [36]p r e -
diction uses protein 3D structure data together with drug-
protein interface information, which is quite diﬀerent to the
approach of gene essentiality, but together these data can be
used to reﬁne drug candidate lists to ﬁnd the most suitable
targets.
As the disease is a balance between virulence at the
bacterial pathogen and host resistance, knocking out a
given protein within the parasite may adversely impact
the host system. This means that for a drug target to be
eﬀective it must take into account the host system. There is,
therefore, a need to also consider the host system in order
to produce a comprehensive map of protein interactions
between pathogen and the human host. Thus, future plans
include development of a host pathogen interaction map for
MTB and human. Furthermore, since most of the hubs are
of unknown function, it would be important to predict their
functions, which is another direction we have pursued.
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